Amber Tong's profile photo

Amber Tong

Hong Kong

Asia Pharmaceuticals Reporter at Bloomberg News

reporter @business covering China + Asia biotech and pharma | formerly @endpts | views are my own | news and tips - [email protected]

Featured in: Favicon endpts.com Favicon governing.com Favicon houstoniamag.com Favicon invesbrain.com Favicon nxtmine.com Favicon advfn.com Favicon newsbreak.com Favicon uaebusinessdaily.com Favicon uaetechnewstracker.com Favicon bloomberg.com

Articles

  • Cheaper Chinese HPV Vaccines Turn Merck’s Gardasil From Boom to Bust

    1 day ago | msn.com | Damian Garde |Karoline Kan |Amber Tong

    Continue reading More for You

  • Cheaper Chinese HPV Vaccines Turn Merck’s Gardasil From Boom to Bust

    1 day ago | bloomberg.com | Damian Garde |Karoline Kan |Amber Tong

    A Chinese woman receives the Gardasil 9 vaccination in 2018. (Bloomberg) -- Merck & Co. Chief Executive Officer Robert Davis was tired of talking about China. On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against cancer-causing HPV in China, which previously powered Merck’s growth. Finally, he had enough. “We need to get the China situation figured out,” he said.

  • Chinese Biotech Eyes US Nod for Cancer Therapy Eluding Merck

    3 weeks ago | bloomberg.com | Amber Tong

    Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers Bloomberg Anywhere Remote Login Software Updates Manage Products and Account Information Support Americas+1 212 318 2000 EMEA+44 20 7330 7500 Asia Pacific+65 6212 1000 Company About Careers Inclusion at Bloomberg Tech at Bloomberg Philanthropy Sustainability Bloomberg London...

  • AstraZeneca Seeks to Move Past China Probe With R&D Hub (1)

    1 month ago | news.bloombergtax.com | Amber Tong |Ashleigh Furlong

    XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

  • AstraZeneca Seeks to Move Past China Probe With Beijing R&D Hub

    1 month ago | news.bloomberglaw.com | Amber Tong |Ashleigh Furlong

    Ever since AstraZeneca Plc shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has tried to maintain a business-as-usual stance in its second-biggest market.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
3K
Tweets
4K
DMs Open
Yes
Amber Tong
Amber Tong @AmberTongPW
4 Apr 25

RT @g0ingmad: Lilly CEO Dave Ricks spoke with ⁦@BBC⁩ about tariffs: “We cant breach those agreements so we have to eat the cost of the tari…

Amber Tong
Amber Tong @AmberTongPW
4 Apr 25

RT @gerryfsmith: New: At least seven people have died in the US from symptoms linked to a new Alzheimer's drug over the past two years. Reg…

Amber Tong
Amber Tong @AmberTongPW
2 Apr 25

Novo Holdings Wants to Do More China Biotech Deals, CEO Says https://t.co/myLxjN9d7l via @business